This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Belgium
Why is this study shown?
This study includes Bipolarity among several conditions.
Depression, BipolarityDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Lithuania
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Netherlands
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Austria
Why is this study shown?
This study includes Bipolarity among several conditions.
Bipolarity, DepressionDrug
Countries
Austria
Sponsor
Universitätsklinik für Psychiatrie und Psychotherapie I
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Denmark
Why is this study shown?
This study includes Bipolarity among several conditions.
Bipolarity, DepressionDrug
Countries
Denmark
Sponsor
Aarhus University Hospital - Psychiatry, Department of Affective Disorders
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Spain
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Czech Republic
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In France
Why is this study shown?
This study includes Bipolarity among several conditions.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Finland
Why is this study shown?
This study includes Bipolarity among several conditions.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
